Surmodics Inc reports results for the quarter ended in March - Earnings Summary

SurModics

26/04/2023 14:32

* Surmodics Inc  SRDX.OQ  reported a quarterly adjusted loss
of 40
cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 51 cents per share.
    * Revenue rose 4.2% to $27.20 million from a year ago;
analysts
expected $25.86 million. 
    * Surmodics Inc's reported EPS for the quarter was a loss
of 55
cents​.
    * The mean earnings estimate of analysts had risen by
about 14.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Surmodics Inc shares had risen by 4.7% this quarter and
lost 30.1% so far this year.
    * The company reported a quarterly loss of $7.73 million.
    * Wall Street's median 12-month price target for Surmodics
Inc is
$60.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 26 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.51          -0.40          Beat
 Dec. 31 2022      -0.66          -0.50          Beat
 Sep. 30 2022      -0.45          -0.26          Beat
 Jun. 30 2022      -0.38          -0.34          Beat